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Triptolide, a diterpenoid isolated from the plant Tripterygium wilfordii Hook. f., exerts
a unique bioactive spectrum of anti-inflammatory and anticancer activities. However,
triptolide’s clinical applications are limited due to its severe toxicities. Fatty liver toxicity
occurs in response to triptolide, and this toxic response significantly differs between
males and females. This report investigated the pathogenesis underlying the sex-related
differences in the dyslipidosis induced by triptolide in rats. Wistar rats were administered
0, 150, 300, or 450 µg triptolide/kg/day by gavage for 28 days. Ultrastructural
examination revealed that more lipid droplets were present in female triptolide-treated
rats than in male triptolide-treated rats. Furthermore, liver triglyceride, total bile acid
and free fatty acid levels were significantly increased in female rats in the 300 and
450 µg/kg dose groups. The expression of liver X receptor α (LXRα) and its target
genes, cholesterol 7α-hydroxylase (CYP7A1) and Sterol regulatory element-binding
transcription factor 1(SREBP-1), increased following triptolide treatment in both male
and female rats; however, the female rats were more sensitive to triptolide than the
male rats. In addition, the expression of acetyl-CoA carboxylase 1(ACC1), a target gene
of SREBP-1, increased in the female rats treated with 450 µg triptolide/kg/day, and
ACC1 expression contributed to the sex-related differences in the triptolide-induced
dysfunction of lipid metabolism. Our results demonstrate that the sex-related differences
in LXR/SREBP-1-mediated regulation of gene expression in rats are responsible for the
sex-related differences in lipid metabolism induced by triptolide, which likely underlie
the sex-related differences in triptolide hepatotoxicity. This study will be important for
predicting sex-related effects on the pharmacokinetics and toxicity of triptolide and for
improving its safety.
Keywords: triptolide, hepatotoxicity, lipid metabolism, liver X receptor α, Sterol regulatory element-binding
transcription factor 1
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INTRODUCTION
Triptolide is a diterpenoid isolated from the plant
Tripterygium wilfordii Hook. f., a member of the Celastraceae
family. Tripterygium wilfordii Hook. f. possesses multiple
pharmacological activities, including anti-inflammatory (Wang
et al., 2014c), anti-fertility (Li et al., 2015), anti-cystogenesis,
and anticancer activities (Li et al., 2015). However, triptolide has
a narrow therapeutic window, and its clinical applications are
limited due to its severe toxicities, including hepatotoxicity (Li
X. et al., 2014), nephrotoxicity (Sun et al., 2013), immunotoxicity
(Wang et al., 2014a), and developmental and reproductive
toxicities (Ni et al., 2008; Ma et al., 2015). Among the adverse
effects of triptolide, hepatotoxicity is non-negligible and has a
high incidence. Our previous toxicokinetic data indicated that
the hepatotoxicity induced by triptolide correlates with its highest
concentration in the liver (unpublished data). Thus, it is essential
to elucidate the mechanism of TP-induced hepatotoxicity.
Sex-related differences in the toxicity of triptolide have
received attention in recent years. Liu et al. (2010) and Liu L. et al.
(2015) reported that there are significant differences between the
sexes in the toxicity of triptolide. These reports indicated that
the sex-related differential expression of Cytochrome P450 3A2
(CYP3A2) in rats is responsible for sexual dimorphic metabolism
of triptolide. Significant gender differences are observed in the
quantity of recovered metabolites, which are likely caused by
the gender-specific expression of sulfotransferases (Liu et al.,
2014). We also previously reported that fatty liver is one
form of toxicity caused by triptolide, and males and females
exhibit significant differences in the degree of this toxicity.
However, the pathogenesis underlying the sex-related differences
in lipid metabolism induced by triptolide has not been elucidated
and remains controversial. To date, mitochondrial respiratory
chain inhibition, oxidative stress, DNA damage, and fatty acid
oxidation have been proposed to be involved in triptolide-
induced hepatotoxicity (Fu et al., 2011; Wang et al., 2013; Wang
et al., 2014b; Liu X. et al., 2015). Although the hepatotoxicity
induced by triptolide in animals and humans has been reported
by many researchers, there is no reasonable explanation for
the sex-related differences in lipid metabolism induced by
triptolide, and it remains an issue of debate. In this study, we
investigated the effects of oral triptolide on lipid metabolism in
rats. The mechanisms underlying the sex-related differences in
lipid metabolism induced by triptolide were examined, and the
present results represent the first evidence that the LXR/SREBP-1
signaling pathway may play an important role.
MATERIALS AND METHODS
Chemicals and Animals
Triptolide (purity > 98%, HPLC) was a gift from the Institute of
Dermatology, Chinese Academy of Medical Sciences and Peking
Union Medical College (Nanjing, China).
Male and female Wistar rats (180–200 g) were obtained from
the Experimental Animal Center of the Academy of Military
Medical Sciences. The animals were housed under identical
conditions in an aseptic facility and given free access to water
and food. Male and female rats were randomly assigned to the
following four groups (n = 10/group): a control group (0.2%
CMC-Na, control solution), a low-dose group (150 µg/kg/day),
a middle dose group (300 µg/kg/day) and a high-dose group
(450 µg/kg/day). The rats were gavaged daily with triptolide for
28 days at 5.36–16.07% of oral lethal dose 50% (2.8 mg/kg),
which was determined in our previous study. The animals
were monitored for the appearance of diarrhea, body weight
loss, and other signs of distress. This study was carried out
in strict accordance with the recommendations in the Guide
for the Care and Use of Laboratory Animals of the National
Institutes of Health. Protocols described were approved by China
Pharmaceutical University Laboratory Animal Care and Use
Committee.
After the rats were exposed to triptolide for 28 days, they
were anasthetized with urethane, and blood was collected via
orbital sinus bleeding for serum chemistry analysis, including
the serum total cholesterol (TC), total bile acid (TBA) and low
density lipoprotein-cholesterol (LDL-C) levels.
Transmission Electron Microscopy
The 1-mm3 thick liver tissue blocks were immediately fixed in
2.5% glutaraldehyde for 2 h at 4◦C. The blocks were then treated
with 1.5% OsO4 in 0.1 M phosphate buffer. After being washed
with distilled water three times, the blocks were dehydrated and
embedded in epoxy resin. Semithin sections were prepared and
stained with toluidine blue. Ultrathin sections of 60 nm were
stained with uranyl acetate and lead citrate and were subsequently
examined with a transmission electron microscope (JEOL 1010,
Japan).
Biochemical Analysis of the Liver Tissue
The liver tissue levels of lipid metabolic parameters [triglyceride
(TG) and free fatty acid (FFA) levels] were determined
by a microplate reader (TECAN Safire II, Austria) using
commercially available colorimetric assay kits (Nanjing Jiancheng
Bioengineering Institute, China). The enzyme rate method
was used to measure the TBA contents with a TBA Reagent
Kit (Witman Biotech, China) using an automatic biochemical
analyzer (Olympus AU2700, Japan).
Enzyme Activity Assays
The enzymes were prepared from liver homogenates and
assayed for acetyl-CoA carboxylase1 (ACC1), 3-hydroxy-3-
methyl-glutaryl-CoA reductase (HMGR) and cholesterol 7-
alpha-hydroxylase (CYP7A1) activity using an enzyme-linked
immunosorbent assay with the respective kits (R&D, USA).
Immunohistochemistry
Immunohistochemical staining was performed on paraffin-
embedded sections (4 µm) using a microwave-based antigen
retrieval technique with a ChemMate Envision kit (Dako,
Denmark). The antibodies used in this study included primary
antibodies against ACC1 (Millipore, USA), SREBP-1 and
CYP7A1 (Santa Cruz, CA, USA). After being immunostained
with secondary antibodies, the sections were developed with
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diaminobenzidine to produce a brown product and were
counterstained with hematoxylin. The stained tissues were
examined by light microscopy (Nikon E600, Japan).
Real-Time Quantitative PCR
Total RNA was prepared from liver samples using TRIzol
Reagent (Invitrogen, USA), and RNA (1 µg) was used for first-
strand cDNA synthesis using RevertAidTM First Strand cDNA
Synthesis Kit (Fermentas, Canada). Real-time quantitative PCR
was performed using gene-specific primers and SYBR Premix
Ex Taq II (TaKaRa, Japan) as a fluorescent dye to detect the
presence of double-stranded DNA by a real-time PCR detection
system (Bio-Rad iQ5, USA). The mRNA values for each gene
were normalized to those of an internal control, β-actin mRNA.
The ratio of the normalized mean value for each treatment group
to the vehicle control group was calculated. The primer sequences
used were as follows: LXRα forward: 5′-TCC TCA GTC TGC
TCC ACC-3′, reverse: 5′-TGC TCT CCG AGA TCT GGG-3′;
ACC1 forward: 5′-AAG GCT ATG TGA AGG ATG-3′, reverse:
5′-CTG TCT GAA GAG GTT AGG-3′; CYP7A1 forward: 5′-
GAC ACA GAA GCA TTG ACC-3′, reverse: 5′-GTA ACA GAA
GGC ATA CAT CC-3′; and SREBP-1 forward: 5′-CAT CAA CAA
CCA AGA CAG TG-3′, reverse: 5′-GAA GCA GGA GAA GAG
AAG C-3′. The thermal cycler conditions included hold for 30 s
at 95◦C, followed by 40 cycles of 5 s at 95◦C and 30 s at 60◦C.
A melting curve analysis was performed for each reaction with a
65–95◦C ramp.
Western Blot Analysis
Nuclear proteins were prepared from rat liver homogenates
using Nucl-Cyto-Mem Preparation Kit (Applygen Technologies,
China), and the protein concentration was determined using the
bicinchoninic acid (BCA) method. The nuclear extracts were
resolved on 12% SDS-poly-acryl amide gels and transferred to
nitrocellulose membranes. Immunoblots were blocked overnight
at 4◦C with 5% BSA in TBS buffer and were incubated
with primary antibodies. Immunoreactive bands were detected
using a horseradish peroxidase–conjugated secondary antibody
and SuperSignal Substrate (Pierce, USA). The signals were
detected using a chemiluminescence detection system (Bio-Rad
ChemiDoc XRS, USA).
Statistical Analysis
The data are expressed as the means ± SD. The significance
of the differences between the groups was evaluated by one-
way analysis of variance (ANOVA) followed by Dunnett’s
multiple comparison post hoc test. Statistics were performed
using GraphPad Pro (GraphPad Software Inc., San Diego, CA,
USA). The differences were considered significant at p< 0.05.
RESULTS
Effects of Triptolide on the TC, TBA, and
LDL-C Levels in Serum
To study the effects of triptolide treatment on lipid metabolism,
we first evaluated the effects of triptolide on the serum chemistry
parameters of the rats. Our results indicated that the serum
TC and LDL-C levels increased after triptolide treatment in
both sexes and there were no statistically significant differences
between male and female. The triptolide-treated female rats
exhibited a significant increase in the level of TBA compared
with the control group; however, this change was not observed
in male rats. For female groups, the serum TBA levels of
triptolide (150, 300, and 450 µg/kg /day)-exposed rats increased
to approximately 33.03% (p < 0.05), 119.89% (p < 0.01), and
228.99% (p< 0.01) than controls, respectively (Figure 1A).
Triptolide Induces Different Levels of
Lipid Accumulation and Ultrastructural
Changes in the Liver of Male and Female
Rats
The TG, FFA and TBA levels in the liver of male and female rats
are presented in Figure 1B. The liver TG levels of female rats
in the 300 and 450 µg/kg /day dose group increased 131.29 %
(p< 0.05) and 380.90% (p< 0.05) more than males, respectively.
For the liver TBA levels, female rats increased 46.47% (300 µg/kg
/day, p< 0.05) and 75.14% (450 µg/kg /day, p< 0.05) more than
males, respectively. For liver FFA levels, the female rats increased
58.66% (p < 0.01), 70.14% (p < 0.01) and 456.58% (p < 0.01)
higher than male rats in the 150, 300, and 450 µg/kg/day
dose group, respectively. The post hoc analysis revealed that the
triptolide-treated female rats exhibited significant increases in
the TG, FFA and TBA levels compared with the control group,
whereas the triptolide-treated male rats exhibited only slight
changes.
Ultrastructural examination by transmission electron
microscopy revealed that the hepatocytes of the triptolide-
treated rats contained many lipid droplets, which accumulated
in the cytosol. In contrast, no fat deposition was observed in
the livers of the control rats. Electron microscopy also revealed
dilated and degranulated rough endoplasmic reticulum (rER)
in the triptolide-treated rats. In addition, the chromatin of
the nucleus was massed and margined, and the mitochondria
were swollen; these characteristics were not observed in the
control rats. Electron microscopy revealed that the severity of
the steatosis differed between female and male rats, and more
lipid droplets were observed in the triptolide-treated female rats
compared with the triptolide-treated male rats (Figure 2).
Effects of Triptolide on the Activities of
Hepatic Lipid Metabolism-Related
Enzymes
The activities of ACC1, HMGR and CYP7A1 in the rat livers
were determined. Figure 3A demonstrates that the hepatic ACC1,
HMGR and CYP7A1 activities were all significantly (p < 0.05)
increased in the triptolide-treated female rats. In the triptolide-
treated male rats, only HMGR activity increased. The activities of
HMGR of female rats in the 300 and 450 µg/kg /day dose group
only showed 10.74% (p > 0.05) and 5.83% (p > 0.05) higher
than males, respectively. There were no significant changes in the
activities of ACC1 or CYP7A1 in the triptolide-treated male rats.
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FIGURE 1 | Effects of triptolide on serum chemistry parameters and hepatic lipid accumulation in rats. (A) The effects of triptolide on the serum levels of
TC, TBA and LDL-C. Serum collected from rats treated with triptolide for 28 days was used for the analysis of the chemistry parameters. (B) The TG, FFA and TBA
levels in the liver. All results are presented as the means ± SD for n = 6 animals for each group. Statistical significance relative to the vehicle control within the female
group: ∗p < 0.05; ∗∗p < 0.01. Statistical significance relative to the vehicle control within male group: #p < 0.05; ##p < 0.01. Single-line brackets indicate the
difference between male and female rats. ∗p < 0.05; ∗∗p < 0.01 for respective control groups by Student’s t-test.
Triptolide Affects the Expression of Key
Genes and Proteins Related to Lipid
Metabolism in the Liver
The effects of triptolide on the expression of the mRNA
(Figure 3B) and proteins (Figures 4 and 5) that are involved
in lipid homeostasis in rats were determined. Compared with
the control group, the mRNA and protein expression levels
of the nuclear receptor, LXRα, significantly increased in both
female and male triptolide-treated rats (Figure 4). The expression
of one of the LXRα target genes, CYP7A1, also significantly
increased in the female rats in the 300 and 450 µg/kg dose
groups. A significant difference in the expression of this gene
was observed between males and females. SREBP-1, another gene
regulated by LXRα, plays a major regulatory role in hepatic lipid
biosynthesis. Real-time PCR demonstrated that SREBP-1 was
more highly expressed in female rats than in male rats. SREBP-
1 expression significantly increased in the female rats in the 300
and 450 µg/kg dose groups. A smaller increase in the expression
of this gene was observed in male rats in the triptolide treatment
groups. The lipogenic enzyme ACC1 is a target gene of SREBP-1.
Real-time PCR revealed that ACC1 was also more highly
expressed in female than male rats. To confirm that CYP7A1,
SREBP-1 and ACC1 are involved in the sex-related differences
in the triptolide-induced dysfunction of lipid metabolism, we
estimated the protein level by immunohistochemical staining
(Figure 5). The expression of CYP7A1, SREBP-1 and ACC1
significantly increased in the female rats in the 450 µg/kg dose
group. A smaller increase in the expression of these genes was
observed in male rats in the triptolide treatment groups.
DISCUSSION
Sex-related differences in human and animal toxicity have
received extensive attention in recent years (Mennecozzi et al.,
Frontiers in Pharmacology | www.frontiersin.org 4 March 2016 | Volume 7 | Article 87
fphar-07-00087 March 31, 2016 Time: 11:24 # 5
Jiang et al. The Sex Differences in Triptolide Toxicity
FIGURE 2 | The results of electron microscopy examination of the liver following triptolide treatment (8000X and 25000X). Rats were administered 0,
150, 300, or 450 µg triptolide/kg/day by gavage for 28 days. Lipid droplets (L); mitochondria (M); rough endoplasmic reticulum (rER) and nuclei (N) are shown. More
lipid droplets (arrow) were observed in the triptolide-treated female rats compared with the male rats.
2015; Meeske et al., 2015). Sex-specific approaches for the
prevention, diagnosis, and treatment of diseases have been
examined for dyslipidemia, cardiovascular disease, metabolic
syndrome, and other conditions (Pradhan, 2014; Barker-
Collo et al., 2015; Brewer et al., 2015). During the past
decade, the role of sex-related differences in lipid metabolism
has been an intense focus of basic research and clinical
treatment approaches. Our previous studies have demonstrated
that triptolide exhibits sex-related differences in its toxicities
(Liu et al., 2010; Tai et al., 2014). Although many reports
have explored the mechanisms of hepatotoxicity induced
by triptolide, no reasonable explanation of the sex-related
differences in lipid metabolism has been found. In this paper,
we investigated the signaling events involved in triptolide-
induced dyslipidosis in the livers of female and male rats. Many
genes, which form complex functional networks, collectively
or cooperatively contribute to the sex-selective toxicity of
drugs (Du et al., 2014; Rohrer et al., 2014). A better
understanding of these links and the interplay among genes
involved in drug toxicity will be of paramount importance for
preventing drug-induced toxicity (Amacher, 2014). Therefore,
in this paper, we investigated the signaling events involved in
triptolide-induced dyslipidosis in the livers of female and male
rats.
The liver is the major organ responsible for maintaining
lipid homeostasis in the body (Hong and Tontonoz, 2014).
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FIGURE 3 | Effects of triptolide on the activities and mRNA expression of hepatic lipid metabolism-related enzymes. (A) The activities of ACC1, HMGR
and CYP7A1 in the livers of female and male rats treated with different doses of triptolide were determined. (B) Real-time PCR analyses of the hepatic mRNA
expression levels of CYP7A1, SREBP-1 and ACC1 were performed for both female and male rats. The gene expression levels represent the relative mRNA
expression compared with the control. All results are presented as the means ± SD for n = 6 animals for each group. Statistical significance relative to the vehicle
control within the female group: ∗p < 0.05; ∗∗p < 0.01. Statistical significance relative to the vehicle control within the male group: #p < 0.05; ##p < 0.01. Single-line
brackets indicate the difference between male and female rats.
Hepatic lipid homeostasis is tightly maintained by a balance
between lipid formation (lipogenesis), catabolism (β-oxidation),
and secretion (Karagianni and Talianidis, 2015). In the present
study, we found that triptolide had different effects on the
lipid metabolism of male and female rats. The liver TG,
TBA and FFA levels increased significantly in female rats in
the 300 and 450 µg/kg dose groups. Female rats were more
sensitive to triptolide than males were. Electron microscopy
revealed that the severity of steatosis caused by triptolide
treatment differed between the female and male rats, and
more lipid droplets were observed in triptolide-treated females
(Figure 2).
LXR belong to the adopted-orphan receptors of the
ligand-activated transcription factor family and form active
heterodimers with the retinoid X receptor (RXR) (Lee et al.,
2015). LXRα and LXRβ are key regulators of lipid and cholesterol
metabolism, including bile acid and fatty acid synthesis (Schultz
et al., 2000; Varin et al., 2015), and play minor or limited
roles in the regulation of cholesterol synthesis and uptake in
mammals. In our study, LXRα mRNA levels were increased
by triptolide treatment in both male and female rats; however,
the female rats were more sensitive to triptolide. Previous
studies have observed noteworthy sex-related differences in
LXR function in the development of atherosclerosis (Alberti
et al., 2001). Transgenic overexpression of LXR in macrophages
led to the upregulation of cholesterol transporters (ABCA1
and ABCG1) and a concomitant reduction in atherosclerotic
lesion size only in male mice (Teupser et al., 2008). Gestational
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FIGURE 4 | Triptolide increases the expression of LXRα in rat livers. Rats were administered 0, 150, 300, or 450 µg triptolide/kg/day by gavage for 28 days.
(A) Real-time PCR analysis of the mRNA levels of LXRα was performed. Statistical significance relative to the vehicle control within the female group: ∗∗p < 0.01.
Statistical significance relative to the vehicle control within the male group: ##p < 0.01. Single-line brackets indicate the difference between male and female rats.
(B) Immunoblots for LXRα from the nuclear extracts of the liver. Lamin B was used as a loading control.
diabetes affects hypothalamic LXR expression differently in
male and female offspring (Kruse et al., 2014; Korach-André
and Gustafsson, 2015). The findings suggest that there are
sex-related differences in the LXR-mediated regulation of
gene expression. Clearly, the LXR signaling pathway leads
to sex-specific modifications in lipid metabolism (Sugiyama
and Agellon, 2012; Korach-André and Gustafsson, 2015).
CYP7A1, a target of LXRα, catalyzes the initial step in the
classical pathway of bile acid synthesis in the liver (Schaap
et al., 2014). Our present results demonstrate that hepatic
CYP7A1 activity and mRNA expression significantly increased
in triptolide-treated female rats, with little change observed in
males. Bile acids are critical for lipid absorption, particularly
cholesterol, fat-soluble vitamins and, to a lesser degree, TGs
(Burke et al., 2009; Zhou and Hylemon, 2014). In addition, the
level of hepatic TBA was significantly increased by triptolide
treatment in female rats but did not significantly change in
males, paralleling the trend observed for CYP7A1 and LXR
(Figure 1).
The SREBP family members, SREBP-1 and SREBP-2, are
synthesized as membrane proteins in the ER (Xiao and
Song, 2013). SREBP-1 governs fatty acid and triacylglyceride
metabolism (Guo et al., 2014; Bitter et al., 2015). In contrast,
SREBP-2 is deeply involved in the regulation of cholesterol
metabolism (Ma et al., 2014) Reflecting such differences in
biological function, the transcript for SREBP-1, which is most
abundant in the liver and adrenal gland, has a shorter acidic
activation domain, and the protein acts selectively to increase
the mRNAs for enzymes involved in fatty acids synthesis
(Soyal et al., 2015). In contrast, the ubiquitously expressed
SREBP-2 transcript has a long activation domain. SREBP-2
is a potent activator of cholesterol synthesis and a weaker
activator of fatty acid biosynthesis (Rice et al., 2014). Améen
et al. (2004) found that the abundance of SREBP-1 mRNA
was greater in female rat livers than in male rat livers.
SREBP-1 is another target gene of LXRα and regulates the
expression of many genes that promote fatty acid and TG
synthesis, including SCD-1, ACC1, and FAS (Lee et al., 2015).
Interestingly, SREBP-1 was significantly increased by triptolide
treatment in the female rats in the 300 and 450 µg/kg dose
groups. A smaller increase in the expression of this gene was
observed in male rats in the triptolide treatment groups. In
addition, the expression of ACC1, the rate-limiting enzyme
for fatty acid synthesis, was markedly induced by 2.4-fold
compared to the control level in female rats exposed to
450 µg triptolide/kg/day. However, no significant differences
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FIGURE 5 | Immunohistochemical staining of liver specimens with anti-CYP7A1, anti-SREBP-1, and anti-ACC1. Rats were administered 0, 150, 300, or
450 µg triptolide/kg/day by gavage for 28 days. The immunostained slides were evaluated and photographed under a microscope (200X; FV-1000; Olympus,
Japan). The intensity of positive brown staining (arrow) is higher in female rats than in male rats of 450 µg/kg dose group. The expression of CYP7A1, SREBP-1 and
ACC1 significantly increased in the female rats in the 450 µg/kg dose group.
were detected between the males in the control and triptolide
treatment groups. Furthermore, we detected significant increases
in the levels of hepatic TGs and FFAs in triptolide-treated female
rats but no significant change in these levels in triptolide-treated
males.
The other SREBP isoform mentioned above, SREBP-2, is
a key regulator of cholesterol homeostasis and acts as a
transcription factor for HMGR (Wong et al., 2015). HMGR,
which is the rate-limiting enzyme in cholesterol biosynthesis,
exhibited no significant increase in rats treated with triptolide
(data not shown). Furthermore, the enzyme activity of HMGR
exhibited a significant increase in both male and female rats
that received 300 and 450 µg triptolide/kg/day. This finding may
reflect only the enzyme activity levels and not any changes in
the mRNA levels, which may have been influenced by other
factors.
Liu et al. (2010) and Tai et al. (2014) reported that there
are significant differences between the sexes in the toxicity of
triptolide. This report indicated that the sex-related differential
expression of CYP3A2 in rats is mainly responsible for the
sexual dimorphism of triptolide metabolism, which may result
in the sex differences in triptolide toxicity. The difference in
plasma and liver exposure to triptolide may be another cause of
the observed sex-related differences in LXR/SREBP-1 expression.
Our future work will focus on evaluation the transcriptional and
post-transcriptional control of lipid homeostasis by triptolide
through LXRα activation. Elucidating how the LXR/SREBP-1
pathway and sex-related factors contribute to the toxicity of
triptolide will be important for predicting sex-related effects on
the pharmacokinetics and toxicity of triptolide and for improving
its safety.
Several research groups have reported that
oxidative stress damage and mitochondrial dysfunction are
important mechanisms underlying triptolide-induced liver
damage (Li J. et al., 2014; Zhou et al., 2014). Our previous
study indicated that the indexes of reactive oxygen species,
such as MDA, SOD and XOD, were also significantly changed
by triptolide in rats. Therefore, determining the indirect
effect of mitochondrial dysfunction and oxidative stress on
triptolide-induced dyslipidosis is an interesting issue.
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CONCLUSION
In conclusion, our findings indicate that triptolide can
cause a significant upregulation of LXR/SREBP-1 signaling
molecules in females, whereas the triptolide-treated male rats
exhibited only slight changes; thus promoting an abnormal
milieu for lipid metabolism which is associated with female
predominance.
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